Pritchard EM - Search Results

1

Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis.

Williams-Karnesky RL, Sandau US, Lusardi TA, Lytle NK, Farrell JM, Pritchard EM, Kaplan DL, Boison D. Williams-Karnesky RL, et al. Among authors: pritchard em. J Clin Invest. 2013 Aug;123(8):3552-63. doi: 10.1172/JCI65636. Epub 2013 Jul 25. J Clin Invest. 2013. PMID: 23863710 Free PMC article.

2

Antiepileptic effects of silk-polymer based adenosine release in kindled rats.

Szybala C, Pritchard EM, Lusardi TA, Li T, Wilz A, Kaplan DL, Boison D. Szybala C, et al. Among authors: pritchard em. Exp Neurol. 2009 Sep;219(1):126-35. doi: 10.1016/j.expneurol.2009.05.018. Epub 2009 May 19. Exp Neurol. 2009. PMID: 19460372 Free PMC article.

3

Silk polymer-based adenosine release: therapeutic potential for epilepsy.

Wilz A, Pritchard EM, Li T, Lan JQ, Kaplan DL, Boison D. Wilz A, et al. Among authors: pritchard em. Biomaterials. 2008 Sep;29(26):3609-16. doi: 10.1016/j.biomaterials.2008.05.010. Epub 2008 Jun 2. Biomaterials. 2008. PMID: 18514814 Free PMC article.

4

Silk fibroin encapsulated powder reservoirs for sustained release of adenosine.

Pritchard EM, Szybala C, Boison D, Kaplan DL. Pritchard EM, et al. J Control Release. 2010 Jun 1;144(2):159-67. doi: 10.1016/j.jconrel.2010.01.035. Epub 2010 Feb 6. J Control Release. 2010. PMID: 20138938 Free PMC article.

5

Silk fibroin biomaterials for controlled release drug delivery.

Pritchard EM, Kaplan DL. Pritchard EM, et al. Expert Opin Drug Deliv. 2011 Jun;8(6):797-811. doi: 10.1517/17425247.2011.568936. Epub 2011 Apr 1. Expert Opin Drug Deliv. 2011. PMID: 21453189 Review.

6

Incorporation of proteinase inhibitors into silk-based delivery devices for enhanced control of degradation and drug release.

Pritchard EM, Valentin T, Boison D, Kaplan DL. Pritchard EM, et al. Biomaterials. 2011 Jan;32(3):909-18. doi: 10.1016/j.biomaterials.2010.09.055. Epub 2010 Oct 14. Biomaterials. 2011. PMID: 20950854 Free PMC article.

7

Self-assembling doxorubicin silk hydrogels for the focal treatment of primary breast cancer.

Seib FP, Pritchard EM, Kaplan DL. Seib FP, et al. Among authors: pritchard em. Adv Funct Mater. 2013 Jan 7;23(1):58-65. doi: 10.1002/adfm.201201238. Adv Funct Mater. 2013. PMID: 23646041 Free PMC article.

8

Effect of silk protein processing on drug delivery from silk films.

Pritchard EM, Hu X, Finley V, Kuo CK, Kaplan DL. Pritchard EM, et al. Macromol Biosci. 2013 Mar;13(3):311-20. doi: 10.1002/mabi.201200323. Epub 2013 Jan 24. Macromol Biosci. 2013. PMID: 23349062 Free PMC article.

9

Antibiotic-Releasing Silk Biomaterials for Infection Prevention and Treatment.

Pritchard EM, Valentin T, Panilaitis B, Omenetto F, Kaplan DL. Pritchard EM, et al. Adv Funct Mater. 2013 Feb 18;23(7):854-861. doi: 10.1002/adfm.201201636. Epub 2012 Sep 26. Adv Funct Mater. 2013. PMID: 23483738 Free PMC article.

10

Review physical and chemical aspects of stabilization of compounds in silk.

Pritchard EM, Dennis PB, Omenetto F, Naik RR, Kaplan DL. Pritchard EM, et al. Biopolymers. 2012 Jun;97(6):479-98. doi: 10.1002/bip.22026. Epub 2012 Jan 23. Biopolymers. 2012. PMID: 22270942 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters